1IA
AUPH icon

1834 Investment Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

1834 Investment Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,000
Closed -$30K – 217
2022
Q2 		$30K Hold
3,000
– – ﹤0.01% 308
2022
Q1 		$37K Sell
3,000
-250
-8% -$3.86K ﹤0.01% 265
2021
Q4 		$74K Sell
3,250
-650
-17% -$15.4K 0.01% 247
2021
Q3 		$86K Sell
3,900
-900
-19% -$14.3K 0.01% 242
2021
Q2 		$62K Buy
4,800
+1,800
+60% +$22.9K 0.01% 262
2021
Q1 		$39K Buy
+3,000
New +$43.5K 0.01% 280

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return